-
Quest Podcast: The People Behind the People: Family Caregiving, Policy, and the Power of Showing Up
In this episode of the Quest Podcast, we chat with Nicole Lucas, a devoted family
-
MDA Ambassador Guest Blog: How to Find Community for Young People Living with Debilitating Diseases
Since her diagnosis with ALS at age 32, Gwen Petersen has poured her energy into
-
Monitoring Duchenne: Strategies for handling symptom changes
Living with Duchenne muscular dystrophy (DMD) means your loved one will need to adapt to
-
Dyne initiates global Phase 3 trial in Duchenne amenable to skipping exon 51, ahead of planned FDA submission for accelerated approval in the US
Dyne Therapeutics, which received early funding from CureDuchenne, is initiating a Phase 3 FORZETTO Trial
-
In my life with DMD, I want to keep paying it forward, one story at a time
This week, I found myself reflecting on how much my life has changed since I
-
CureDuchenne Announces Partnership with Tevard Biosciences to Advance Suppressor tRNA Therapy for the Treatment of Duchenne Muscular Dystrophy
Tevard Biosciences to present most recent data to Duchenne community for first time at CureDuchenne
-
Dyne Announces Phase 3 Trial of Z-Rostudirsen, Plans for Submitting Biologics License Application to FDA
Dyne Therapeutics today announced the initiation of the company’s Phase 3 FORZETTO trial of zeleciment
-
CureDuchenne Appoints Lidia Gardner, PhD, EMBA, as Vice President of Clinical and Medical Affairs to Advance Patient-Centered Care, Research, and Strategic Partnerships
NEWPORT BEACH, Calif., May 20, 2026 /PRNewswire/ — CureDuchenne, a global nonprofit committed to finding and funding a
-
RGX-202 gene therapy meets main goal in Phase 3 DMD clinical trial
The Phase 3 portion of a clinical trial testing RGX-202, an investigational gene therapy for
-
When it comes to raising a child with DMD, the third time is not the charm
They say the third time is the charm. However, as a mom to three sons
